Awareness, value and use of the Australian living guidelines for the clinical care of people with COVID-19: an impact evaluation

Millard, Tanya; Elliott, Julian; Green, Sally; Tendal, Britta; Vogel, Joshua P.; Norris, Sarah; Tate, Rhiannon; Turner, Tari

doi:10.1016/j.jclinepi.2021.11.035

Cited by 15 publications

(10 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following the outbreak of the pandemic, this work accelerated. With funding from the federal and Victoria state health departments, they collaborated with a wide range of 31 (later 32) peak professional and policy stakeholders to create a national system of living clinical guidelines first published in March 2020, updated over 70 times by December 2021, and quite widely used by practitioners and policy-makers [24][25][26]236]. Just as with primary and secondary research, a clear lesson seems to be that major, national, coordinated initiatives, with a high level of user involvement, seem more likely to produce highquality outputs (in this case guidelines) that are valued and used, and that stand out from the explosion of small/ poor-quality ones [42].…”

Section: Australia Including Nswmentioning

confidence: 99%

Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges

Hanney

Straus

Holmes

2022

Health Res Policy Sys

View full text Add to dashboard Cite

During the SARS-CoV-2 pandemic, astonishingly rapid research averted millions of deaths worldwide through new vaccines and repurposed and new drugs. Evidence use informed life-saving national policies including non-pharmaceutical interventions. Simultaneously, there was unprecedented waste, with many underpowered trials on the same drugs. We identified lessons from COVID-19 research responses by applying WHO’s framework for research systems. It has four functions—governance, securing finance, capacity-building, and production and use of research—and nine components. Two linked questions focused the analysis. First, to what extent have achievements in knowledge production and evidence use built on existing structures and capacity in national health research systems? Second, did the features of such systems mitigate waste? We collated evidence on seven countries, Australia, Brazil, Canada, Germany, New Zealand, the United Kingdom and the United States, to identify examples of achievements and challenges.We used the data to develop lessons for each framework component. Research coordination, prioritization and expedited ethics approval contributed to rapid identification of new therapies, including dexamethasone in the United Kingdom and Brazil. Accelerated vaccines depended on extensive funding, especially through the Operation Warp Speed initiative in the United States, and new platforms created through long-term biomedical research capacity in the United Kingdom and, for messenger ribonucleic acid (mRNA) vaccines, in Canada, Germany and the United States. Research capacity embedded in the United Kingdom’s healthcare system resulted in trial acceleration and waste avoidance. Faster publication of research saved lives, but raised challenges. Public/private collaborations made major contributions to vastly accelerating new products, available worldwide, though unequally. Effective developments of living (i.e. regularly updated) reviews and guidelines, especially in Australia and Canada, extended existing expertise in meeting users’ needs. Despite complexities, effective national policy responses (less evident in Brazil, the United Kingdom and the United States) also saved lives by drawing on health research system features, including collaboration among politicians, civil servants and researchers; good communications; and willingness to use evidence. Comprehensive health research strategies contributed to success in research production in the United Kingdom and in evidence use by political leadership in New Zealand. In addition to waste, challenges included equity issues, public involvement and non-COVID research. We developed recommendations, but advocate studies of further countries.

show abstract

Section: Australia Including Nswmentioning

confidence: 99%

Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges

Hanney

Straus

Holmes

2022

Health Res Policy Sys

View full text Add to dashboard Cite

show abstract

“…It showed that awareness of the work of the Taskforce was high and the vast majority of respondents reported that the guidelines were very or extremely relevant, easy to use, trustworthy and valuable. 29 The evaluation highlighted that the guidelines had been a reliable, united source of evidence‐based advice, built confidence among health care practitioners in providing care, and provided them with reassurance in clinical decision making. The Taskforce website, flowcharts and recommendations have been widely used in Australia and overseas.…”

Section: Impact Of the Guidelinesmentioning

confidence: 99%

“…Towards the end of 2020, a process evaluation was conducted, which targeted Australian health care practitioners who potentially provide care to individuals with suspected or confirmed COVID‐19. It showed that awareness of the work of the Taskforce was high and the vast majority of respondents reported that the guidelines were very or extremely relevant, easy to use, trustworthy and valuable 29 . The evaluation highlighted that the guidelines had been a reliable, united source of evidence‐based advice, built confidence among health care practitioners in providing care, and provided them with reassurance in clinical decision making.…”

Section: Impact Of the Guidelinesmentioning

confidence: 99%

The National COVID ‐19 Clinical Evidence Taskforce: pregnancy and perinatal guidelines

Homer

Roach

Cusack

et al. 2022

Medical Journal of Australia

Self Cite

View full text Add to dashboard Cite

Introduction Pregnant women are at higher risk of severe illness from coronavirus disease 2019 (COVID‐19) than non‐pregnant women of a similar age. Early in the COVID‐19 pandemic, it was clear that evidenced‐based guidance was needed, and that it would need to be updated rapidly. The National COVID‐19 Clinical Evidence Taskforce provided a resource to guide care for people with COVID‐19, including during pregnancy. Care for pregnant and breastfeeding women and their babies was included as a priority when the Taskforce was set up, with a Pregnancy and Perinatal Care Panel convened to guide clinical practice. Main recommendations As of May 2022, the Taskforce has made seven specific recommendations on care for pregnant women and those who have recently given birth. This includes supporting usual practices for the mode of birth, umbilical cord clamping, skin‐to‐skin contact, breastfeeding, rooming‐in, and using antenatal corticosteroids and magnesium sulfate as clinically indicated. There are 11 recommendations for COVID‐19‐specific treatments, including conditional recommendations for using remdesivir, tocilizumab and sotrovimab. Finally, there are recommendations not to use several disease‐modifying treatments for the treatment of COVID‐19, including hydroxychloroquine and ivermectin. The recommendations are continually updated to reflect new evidence, and the most up‐to‐date guidance is available online ( https://covid19evidence.net.au ). Changes in management resulting from the guidelines The National COVID‐19 Clinical Evidence Taskforce has been a critical component of the infrastructure to support Australian maternity care providers during the COVID‐19 pandemic. The Taskforce has shown that a rapid living guidelines approach is feasible and acceptable.

show abstract

“…[20] There is a significant body of literature on BPGs in the direct practice domain addressing a broad range of foci, including the evidence base of BPGs, implementation and integration, and quality and impact evaluation. [21][22][23][24][25][26][27] The implementation of RNAO's BPGs in hospitals and primary care centers in Canada and internationally has been the subject of numerous scholarly works, including research papers. [28][29][30][31][32][33] Kingsnorth and colleagues' evaluation of a multifaceted implementation strategy to support the adoption of an RNAO BPG on the assessment and management of acute pain in a pediatric rehabilitation and complex continuing care hospital found significant improvements in nurses' knowledge, attitudes, and behaviours related to optimal pain care for children with disabilities.…”

Section: The Canadian Contextmentioning

confidence: 99%

Reflections on fostering student nurse evidence-based practice competencies via integration of nursing best practice guidelines

Ewers

Anyinam²,

Davis³

2022

JNEP

View full text Add to dashboard Cite

Evidence-based nursing practice has been identified as an important nurse competency and standard of practice by nurse regulators and nurse educators in both the United States and Canada, yet little is known about the curricular strategies which foster development of evidence-based competencies in the undergraduate nursing context. Although there are several evidence-based practice models that are being used by nurses, much of the literature reflects evidence-based practice implementation strategies which are focused on nurses already in practice. It remains unclear how evidence-based practice competencies are being taught to undergraduate nursing students. In the Canadian context, the Registered Nurses’ Association of Ontario, promotes the implementation of Nursing Best Practice Guidelines as a viable strategy for implementing evidence-base nursing practice in both the clinical and academic contexts. Clinical and academic institutions that implement best practice guidelines and meet the outcome criteria of the Registered Nurses Association may be designated as a Best Practice Spotlight Organization. In this paper, two of the authors reflect on the curricular strategies they used to integrate Best Practice Guidelines into selected undergraduate nursing courses and the challenges and opportunities that this engendered as part of their university school of nursing’s journey to achieve designation as a Best Practice Spotlight Organization (Academic).

show abstract

Awareness, value and use of the Australian living guidelines for the clinical care of people with COVID-19: an impact evaluation

Cited by 15 publications

References 9 publications

Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges

Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges

The National COVID ‐19 Clinical Evidence Taskforce: pregnancy and perinatal guidelines

Reflections on fostering student nurse evidence-based practice competencies via integration of nursing best practice guidelines

Contact Info

Product

Resources

About